NCT01928472View on ClinicalTrials.gov

Dose-finding Study of Four Dosage Levels of an H7N9 Influenza Vaccine in Adults Between Ages of 18 Years and 65 Years

PHASE1CompletedINTERVENTIONAL
Enrollment

402

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
H7N9 Influenza
Interventions
BIOLOGICAL

H7N9c low dose with adjuvant

BIOLOGICAL

H7N9c medium dose with adjuvant

BIOLOGICAL

H7N9c high dose with adjuvant

BIOLOGICAL

H7N9c high dose without adjuvant

Trial Locations (6)

20850

Site 03: Accelovance, Rockville

32935

Site 01: Accelovance, Melbourne

61602

Site 02: Accelovance, Peoria

84109

Site 05: Janet Lewis, Salt Lake City

84121

Site 06: Janet Lewis, Salt Lake City

92108

Site 04: Accelovance, San Diego

Sponsors

Lead Sponsor

Novartis Vaccines
All Listed Sponsors
lead

Novartis Vaccines

INDUSTRY